APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Retinal Drugs and Biologics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Retinal Drugs and Biologics Market Analysis and Forecast 2026-2032

Report ID 174032610222 December 2025191 pages

Choose your research edition.

Industry ResearchRetinal Drugs and Biologics Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Retinal Drugs and Biologics Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Retinal Drugs and Biologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Retinal Drugs and Biologics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Retinal Drugs and Biologics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Retinal Drugs and Biologics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Retinal Drugs and Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Retinal Drugs and Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Retinal Drugs and Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Retinal Drugs and Biologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Retinal Drugs and Biologics include ALLERGAN, Alimera Sciences, Bausch & Lomb, Bristol-Myers Squibb, Genentech, Genzyme, Janssen Biotech, OCULAR THERAPEUTIX and Swedish Orphan Biovitrum, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Retinal Drugs and Biologics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Retinal Drugs and Biologics, also provides the sales of main regions and countries. Of the upcoming market potential for Retinal Drugs and Biologics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Retinal Drugs and Biologics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Retinal Drugs and Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Retinal Drugs and Biologics sales, projected growth trends, production technology, application and end-user industry.

Retinal Drugs and Biologics Segment by Company

ALLERGAN

Alimera Sciences

Bausch & Lomb

Bristol-Myers Squibb

Genentech

Genzyme

Janssen Biotech

OCULAR THERAPEUTIX

Swedish Orphan Biovitrum

UCBCares

AbbVie

Roche

Retinal Drugs and Biologics Segment by Type

Ocular Inflammatory Disease (Uveitis)

Diabetic Retinopathy

Age Related Macular Degeneration

Macular Hole

Retinal Drugs and Biologics Segment by Application

Hospitals

Clinics

Others

Retinal Drugs and Biologics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Retinal Drugs and Biologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Retinal Drugs and Biologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Retinal Drugs and Biologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Retinal Drugs and Biologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Retinal Drugs and Biologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Retinal Drugs and Biologics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Retinal Drugs and Biologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ocular Inflammatory Disease (Uveitis) Major Manufacturers Table 3. Diabetic Retinopathy Major Manufacturers Table 4. Age Related Macular Degeneration Major Manufacturers Table 5. Macular Hole Major Manufacturers Table 6. Global Retinal Drugs and Biologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Manufacturers Table 8. Clinics Major Manufacturers Table 9. Others Major Manufacturers Table 10. Retinal Drugs and Biologics Industry Trends Table 11. Retinal Drugs and Biologics Industry Drivers Table 12. Retinal Drugs and Biologics Industry Opportunities and Challenges Table 13. Retinal Drugs and Biologics Industry Restraints Table 14. Global Retinal Drugs and Biologics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Retinal Drugs and Biologics Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Retinal Drugs and Biologics Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Retinal Drugs and Biologics Revenue Market Share by Region (2021-2026) Table 18. Global Retinal Drugs and Biologics Revenue Market Share by Region (2027-2032) Table 19. Global Retinal Drugs and Biologics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 20. Global Retinal Drugs and Biologics Sales by Region (2021-2026) & (k tons) Table 21. Global Retinal Drugs and Biologics Sales by Region (2027-2032) & (k tons) Table 22. Global Retinal Drugs and Biologics Sales Market Share by Region (2021-2026) Table 23. Global Retinal Drugs and Biologics Sales Market Share by Region (2027-2032) Table 24. Global Retinal Drugs and Biologics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Retinal Drugs and Biologics Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Retinal Drugs and Biologics Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2021-2026) Table 28. Global Retinal Drugs and Biologics Sales Price (US$/ton) of Manufacturers (2021-2026) Table 29. Global Retinal Drugs and Biologics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Retinal Drugs and Biologics Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Retinal Drugs and Biologics Manufacturers, Product Type & Application Table 32. Global Retinal Drugs and Biologics Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Retinal Drugs and Biologics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Retinal Drugs and Biologics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Retinal Drugs and Biologics Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Retinal Drugs and Biologics Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Retinal Drugs and Biologics Revenue Market Share by Type (2021-2026) Table 39. Global Retinal Drugs and Biologics Revenue Market Share by Type (2027-2032) Table 40. Global Retinal Drugs and Biologics Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 41. Global Retinal Drugs and Biologics Sales by Type (2021-2026) & (k tons) Table 42. Global Retinal Drugs and Biologics Sales by Type (2027-2032) & (k tons) Table 43. Global Retinal Drugs and Biologics Sales Market Share by Type (2021-2026) Table 44. Global Retinal Drugs and Biologics Sales Market Share by Type (2027-2032) Table 45. Global Retinal Drugs and Biologics Price by Type (2021-2026) & (US$/ton) Table 46. Global Retinal Drugs and Biologics Price by Type (2027-2032) & (US$/ton) Table 47. Global Retinal Drugs and Biologics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Retinal Drugs and Biologics Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Retinal Drugs and Biologics Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Retinal Drugs and Biologics Revenue Market Share by Application (2021-2026) Table 51. Global Retinal Drugs and Biologics Revenue Market Share by Application (2027-2032) Table 52. Global Retinal Drugs and Biologics Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 53. Global Retinal Drugs and Biologics Sales by Application (2021-2026) & (k tons) Table 54. Global Retinal Drugs and Biologics Sales by Application (2027-2032) & (k tons) Table 55. Global Retinal Drugs and Biologics Sales Market Share by Application (2021-2026) Table 56. Global Retinal Drugs and Biologics Sales Market Share by Application (2027-2032) Table 57. Global Retinal Drugs and Biologics Price by Application (2021-2026) & (US$/ton) Table 58. Global Retinal Drugs and Biologics Price by Application (2027-2032) & (US$/ton) Table 59. ALLERGAN Company Information Table 60. ALLERGAN Business Overview Table 61. ALLERGAN Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 62. ALLERGAN Retinal Drugs and Biologics Product Portfolio Table 63. ALLERGAN Recent Development Table 64. Alimera Sciences Company Information Table 65. Alimera Sciences Business Overview Table 66. Alimera Sciences Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 67. Alimera Sciences Retinal Drugs and Biologics Product Portfolio Table 68. Alimera Sciences Recent Development Table 69. Bausch & Lomb Company Information Table 70. Bausch & Lomb Business Overview Table 71. Bausch & Lomb Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 72. Bausch & Lomb Retinal Drugs and Biologics Product Portfolio Table 73. Bausch & Lomb Recent Development Table 74. Bristol-Myers Squibb Company Information Table 75. Bristol-Myers Squibb Business Overview Table 76. Bristol-Myers Squibb Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 77. Bristol-Myers Squibb Retinal Drugs and Biologics Product Portfolio Table 78. Bristol-Myers Squibb Recent Development Table 79. Genentech Company Information Table 80. Genentech Business Overview Table 81. Genentech Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 82. Genentech Retinal Drugs and Biologics Product Portfolio Table 83. Genentech Recent Development Table 84. Genzyme Company Information Table 85. Genzyme Business Overview Table 86. Genzyme Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 87. Genzyme Retinal Drugs and Biologics Product Portfolio Table 88. Genzyme Recent Development Table 89. Janssen Biotech Company Information Table 90. Janssen Biotech Business Overview Table 91. Janssen Biotech Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 92. Janssen Biotech Retinal Drugs and Biologics Product Portfolio Table 93. Janssen Biotech Recent Development Table 94. OCULAR THERAPEUTIX Company Information Table 95. OCULAR THERAPEUTIX Business Overview Table 96. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 97. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Portfolio Table 98. OCULAR THERAPEUTIX Recent Development Table 99. Swedish Orphan Biovitrum Company Information Table 100. Swedish Orphan Biovitrum Business Overview Table 101. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 102. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Portfolio Table 103. Swedish Orphan Biovitrum Recent Development Table 104. UCBCares Company Information Table 105. UCBCares Business Overview Table 106. UCBCares Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 107. UCBCares Retinal Drugs and Biologics Product Portfolio Table 108. UCBCares Recent Development Table 109. AbbVie Company Information Table 110. AbbVie Business Overview Table 111. AbbVie Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 112. AbbVie Retinal Drugs and Biologics Product Portfolio Table 113. AbbVie Recent Development Table 114. Roche Company Information Table 115. Roche Business Overview Table 116. Roche Retinal Drugs and Biologics Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 117. Roche Retinal Drugs and Biologics Product Portfolio Table 118. Roche Recent Development Table 119. North America Retinal Drugs and Biologics Revenue by Type (2021-2026) & (US$ Million) Table 120. North America Retinal Drugs and Biologics Revenue by Type (2027-2032) & (US$ Million) Table 121. North America Retinal Drugs and Biologics Sales by Type (2021-2026) & (k tons) Table 122. North America Retinal Drugs and Biologics Sales by Type (2027-2032) & (k tons) Table 123. North America Retinal Drugs and Biologics Sales Price by Type (2021-2026) & (US$/ton) Table 124. North America Retinal Drugs and Biologics Sales Price by Type (2027-2032) & (US$/ton) Table 125. North America Retinal Drugs and Biologics Revenue by Application (2021-2026) & (US$ Million) Table 126. North America Retinal Drugs and Biologics Revenue by Application (2027-2032) & (US$ Million) Table 127. North America Retinal Drugs and Biologics Sales by Application (2021-2026) & (k tons) Table 128. North America Retinal Drugs and Biologics Sales by Application (2027-2032) & (k tons) Table 129. North America Retinal Drugs and Biologics Sales Price by Application (2021-2026) & (US$/ton) Table 130. North America Retinal Drugs and Biologics Sales Price by Application (2027-2032) & (US$/ton) Table 131. North America Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Retinal Drugs and Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. North America Retinal Drugs and Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. North America Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 135. North America Retinal Drugs and Biologics Sales by Country (2021-2026) & (k tons) Table 136. North America Retinal Drugs and Biologics Sales by Country (2027-2032) & (k tons) Table 137. North America Retinal Drugs and Biologics Sales Price by Country (2021-2026) & (US$/ton) Table 138. North America Retinal Drugs and Biologics Sales Price by Country (2027-2032) & (US$/ton) Table 139. United States Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 140. Canada Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 141. Mexico Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 142. Europe Retinal Drugs and Biologics Revenue by Type (2021-2026) & (US$ Million) Table 143. Europe Retinal Drugs and Biologics Revenue by Type (2027-2032) & (US$ Million) Table 144. Europe Retinal Drugs and Biologics Sales by Type (2021-2026) & (k tons) Table 145. Europe Retinal Drugs and Biologics Sales by Type (2027-2032) & (k tons) Table 146. Europe Retinal Drugs and Biologics Sales Price by Type (2021-2026) & (US$/ton) Table 147. Europe Retinal Drugs and Biologics Sales Price by Type (2027-2032) & (US$/ton) Table 148. Europe Retinal Drugs and Biologics Revenue by Application (2021-2026) & (US$ Million) Table 149. Europe Retinal Drugs and Biologics Revenue by Application (2027-2032) & (US$ Million) Table 150. Europe Retinal Drugs and Biologics Sales by Application (2021-2026) & (k tons) Table 151. Europe Retinal Drugs and Biologics Sales by Application (2027-2032) & (k tons) Table 152. Europe Retinal Drugs and Biologics Sales Price by Application (2021-2026) & (US$/ton) Table 153. Europe Retinal Drugs and Biologics Sales Price by Application (2027-2032) & (US$/ton) Table 154. Europe Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe Retinal Drugs and Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. Europe Retinal Drugs and Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. Europe Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 158. Europe Retinal Drugs and Biologics Sales by Country (2021-2026) & (k tons) Table 159. Europe Retinal Drugs and Biologics Sales by Country (2027-2032) & (k tons) Table 160. Europe Retinal Drugs and Biologics Sales Price by Country (2021-2026) & (US$/ton) Table 161. Europe Retinal Drugs and Biologics Sales Price by Country (2027-2032) & (US$/ton) Table 162. Germany Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 163. France Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 164. U.K. Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 165. Italy Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 166. Russia Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 167. Spain Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 168. Netherlands Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 169. Switzerland Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 170. Sweden Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 171. Poland Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 172. China Retinal Drugs and Biologics Revenue by Type (2021-2026) & (US$ Million) Table 173. China Retinal Drugs and Biologics Revenue by Type (2027-2032) & (US$ Million) Table 174. China Retinal Drugs and Biologics Sales by Type (2021-2026) & (k tons) Table 175. China Retinal Drugs and Biologics Sales by Type (2027-2032) & (k tons) Table 176. China Retinal Drugs and Biologics Sales Price by Type (2021-2026) & (US$/ton) Table 177. China Retinal Drugs and Biologics Sales Price by Type (2027-2032) & (US$/ton) Table 178. China Retinal Drugs and Biologics Revenue by Application (2021-2026) & (US$ Million) Table 179. China Retinal Drugs and Biologics Revenue by Application (2027-2032) & (US$ Million) Table 180. China Retinal Drugs and Biologics Sales by Application (2021-2026) & (k tons) Table 181. China Retinal Drugs and Biologics Sales by Application (2027-2032) & (k tons) Table 182. China Retinal Drugs and Biologics Sales Price by Application (2021-2026) & (US$/ton) Table 183. China Retinal Drugs and Biologics Sales Price by Application (2027-2032) & (US$/ton) Table 184. Asia Retinal Drugs and Biologics Revenue by Type (2021-2026) & (US$ Million) Table 185. Asia Retinal Drugs and Biologics Revenue by Type (2027-2032) & (US$ Million) Table 186. Asia Retinal Drugs and Biologics Sales by Type (2021-2026) & (k tons) Table 187. Asia Retinal Drugs and Biologics Sales by Type (2027-2032) & (k tons) Table 188. Asia Retinal Drugs and Biologics Sales Price by Type (2021-2026) & (US$/ton) Table 189. Asia Retinal Drugs and Biologics Sales Price by Type (2027-2032) & (US$/ton) Table 190. Asia Retinal Drugs and Biologics Revenue by Application (2021-2026) & (US$ Million) Table 191. Asia Retinal Drugs and Biologics Revenue by Application (2027-2032) & (US$ Million) Table 192. Asia Retinal Drugs and Biologics Sales by Application (2021-2026) & (k tons) Table 193. Asia Retinal Drugs and Biologics Sales by Application (2027-2032) & (k tons) Table 194. Asia Retinal Drugs and Biologics Sales Price by Application (2021-2026) & (US$/ton) Table 195. Asia Retinal Drugs and Biologics Sales Price by Application (2027-2032) & (US$/ton) Table 196. Asia Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Asia Retinal Drugs and Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. Asia Retinal Drugs and Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. Asia Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 200. Asia Retinal Drugs and Biologics Sales by Country (2021-2026) & (k tons) Table 201. Asia Retinal Drugs and Biologics Sales by Country (2027-2032) & (k tons) Table 202. Asia Retinal Drugs and Biologics Sales Price by Country (2021-2026) & (US$/ton) Table 203. Asia Retinal Drugs and Biologics Sales Price by Country (2027-2032) & (US$/ton) Table 204. Japan Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 205. South Korea Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 206. India Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 207. Australia Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 208. Taiwan Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 209. Southeast Asia Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 210. SAMEA Retinal Drugs and Biologics Revenue by Type (2021-2026) & (US$ Million) Table 211. SAMEA Retinal Drugs and Biologics Revenue by Type (2027-2032) & (US$ Million) Table 212. SAMEA Retinal Drugs and Biologics Sales by Type (2021-2026) & (k tons) Table 213. SAMEA Retinal Drugs and Biologics Sales by Type (2027-2032) & (k tons) Table 214. SAMEA Retinal Drugs and Biologics Sales Price by Type (2021-2026) & (US$/ton) Table 215. SAMEA Retinal Drugs and Biologics Sales Price by Type (2027-2032) & (US$/ton) Table 216. SAMEA Retinal Drugs and Biologics Revenue by Application (2021-2026) & (US$ Million) Table 217. SAMEA Retinal Drugs and Biologics Revenue by Application (2027-2032) & (US$ Million) Table 218. SAMEA Retinal Drugs and Biologics Sales by Application (2021-2026) & (k tons) Table 219. SAMEA Retinal Drugs and Biologics Sales by Application (2027-2032) & (k tons) Table 220. SAMEA Retinal Drugs and Biologics Sales Price by Application (2021-2026) & (US$/ton) Table 221. SAMEA Retinal Drugs and Biologics Sales Price by Application (2027-2032) & (US$/ton) Table 222. SAMEA Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 223. SAMEA Retinal Drugs and Biologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 224. SAMEA Retinal Drugs and Biologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 225. SAMEA Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 226. SAMEA Retinal Drugs and Biologics Sales by Country (2021-2026) & (k tons) Table 227. SAMEA Retinal Drugs and Biologics Sales by Country (2027-2032) & (k tons) Table 228. SAMEA Retinal Drugs and Biologics Sales Price by Country (2021-2026) & (US$/ton) Table 229. SAMEA Retinal Drugs and Biologics Sales Price by Country (2027-2032) & (US$/ton) Table 230. Brazil Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 231. Argentina Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 232. Chile Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 233. Colombia Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 234. Peru Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 235. Saudi Arabia Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 236. Israel Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 237. UAE Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 238. Turkey Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 239. Iran Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 240. Egypt Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Table 241. Key Raw Materials Table 242. Raw Materials Key Suppliers Table 243. Retinal Drugs and Biologics Distributors List Table 244. Retinal Drugs and Biologics Customers List Table 245. Research Programs/Design for This Report Table 246. Authors List of This Report Table 247. Secondary Sources Table 248. Primary Sources List of Figures Figure 1. Retinal Drugs and Biologics Image Figure 2. Global Retinal Drugs and Biologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Retinal Drugs and Biologics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ocular Inflammatory Disease (Uveitis) Image Figure 5. Diabetic Retinopathy Image Figure 6. Age Related Macular Degeneration Image Figure 7. Macular Hole Image Figure 8. Global Retinal Drugs and Biologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Retinal Drugs and Biologics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Clinics Image Figure 12. Others Image Figure 13. Global Retinal Drugs and Biologics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Retinal Drugs and Biologics Revenue (2021-2032) & (US$ Million) Figure 15. Global Retinal Drugs and Biologics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Retinal Drugs and Biologics Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Retinal Drugs and Biologics Revenue Market Share by Region (2021-2032) Figure 18. Global Retinal Drugs and Biologics Sales (2021-2032) & (k tons) Figure 19. Global Retinal Drugs and Biologics Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 20. Global Retinal Drugs and Biologics Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Retinal Drugs and Biologics Sales YoY (2021-2032) & (k tons) Figure 22. Europe Retinal Drugs and Biologics Sales YoY (2021-2032) & (k tons) Figure 23. China Retinal Drugs and Biologics Sales YoY (2021-2032) & (k tons) Figure 24. Asia (Excluding China) Retinal Drugs and Biologics Sales YoY (2021-2032) & (k tons) Figure 25. South America, Middle East and Africa Retinal Drugs and Biologics Sales YoY (2021-2032) & (k tons) Figure 26. Global Retinal Drugs and Biologics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Retinal Drugs and Biologics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Retinal Drugs and Biologics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Retinal Drugs and Biologics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Retinal Drugs and Biologics Revenue Market Share by Type (2021-2032) Figure 32. Global Retinal Drugs and Biologics Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 33. Global Retinal Drugs and Biologics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Retinal Drugs and Biologics Sales Market Share by Type (2021-2032) Figure 35. Global Retinal Drugs and Biologics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Retinal Drugs and Biologics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Retinal Drugs and Biologics Revenue Market Share by Application (2021-2032) Figure 38. Global Retinal Drugs and Biologics Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 39. Global Retinal Drugs and Biologics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Retinal Drugs and Biologics Sales Market Share by Application (2021-2032) Figure 41. North America Retinal Drugs and Biologics Revenue Share by Type (2021-2032) Figure 42. North America Retinal Drugs and Biologics Sales Share by Type (2021-2032) Figure 43. North America Retinal Drugs and Biologics Revenue Share by Application (2021-2032) Figure 44. North America Retinal Drugs and Biologics Sales Share by Application (2021-2032) Figure 45. North America Retinal Drugs and Biologics Revenue Share by Country (2021-2032) Figure 46. North America Retinal Drugs and Biologics Sales Share by Country (2021-2032) Figure 47. Europe Retinal Drugs and Biologics Revenue Share by Type (2021-2032) Figure 48. Europe Retinal Drugs and Biologics Sales Share by Type (2021-2032) Figure 49. Europe Retinal Drugs and Biologics Revenue Share by Application (2021-2032) Figure 50. Europe Retinal Drugs and Biologics Sales Share by Application (2021-2032) Figure 51. Europe Retinal Drugs and Biologics Revenue Share by Country (2021-2032) Figure 52. Europe Retinal Drugs and Biologics Sales Share by Country (2021-2032) Figure 53. China Retinal Drugs and Biologics Revenue Share by Type (2021-2032) Figure 54. China Retinal Drugs and Biologics Sales Share by Type (2021-2032) Figure 55. China Retinal Drugs and Biologics Revenue Share by Application (2021-2032) Figure 56. China Retinal Drugs and Biologics Sales Share by Application (2021-2032) Figure 57. Asia Retinal Drugs and Biologics Revenue Share by Type (2021-2032) Figure 58. Asia Retinal Drugs and Biologics Sales Share by Type (2021-2032) Figure 59. Asia Retinal Drugs and Biologics Revenue Share by Application (2021-2032) Figure 60. Asia Retinal Drugs and Biologics Sales Share by Application (2021-2032) Figure 61. Asia Retinal Drugs and Biologics Revenue Share by Country (2021-2032) Figure 62. Asia Retinal Drugs and Biologics Sales Share by Country (2021-2032) Figure 63. SAMEA Retinal Drugs and Biologics Revenue Share by Type (2021-2032) Figure 64. SAMEA Retinal Drugs and Biologics Sales Share by Type (2021-2032) Figure 65. SAMEA Retinal Drugs and Biologics Revenue Share by Application (2021-2032) Figure 66. SAMEA Retinal Drugs and Biologics Sales Share by Application (2021-2032) Figure 67. SAMEA Retinal Drugs and Biologics Revenue Share by Country (2021-2032) Figure 68. SAMEA Retinal Drugs and Biologics Sales Share by Country (2021-2032) Figure 69. Retinal Drugs and Biologics Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Retinal Drugs and Biologics Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Ocular Inflammatory Disease (Uveitis)
  • Diabetic Retinopathy
  • Age Related Macular Degeneration
  • Macular Hole
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • ALLERGAN
  • Alimera Sciences
  • Bausch & Lomb
  • Bristol-Myers Squibb
  • Genentech
  • Genzyme
  • Janssen Biotech
  • OCULAR THERAPEUTIX
  • Swedish Orphan Biovitrum
  • UCBCares
  • AbbVie
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Retinal Drugs and Biologics Market by Type
  3. 1.2.1 Global Retinal Drugs and Biologics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ocular Inflammatory Disease (Uveitis)
  5. 1.2.3 Diabetic Retinopathy
  6. 1.2.4 Age Related Macular Degeneration
  7. 1.2.5 Macular Hole
  8. 1.3 Retinal Drugs and Biologics Market by Application
  9. 1.3.1 Global Retinal Drugs and Biologics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Clinics
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Retinal Drugs and Biologics Market Dynamics
  1. 2.1 Retinal Drugs and Biologics Industry Trends
  2. 2.2 Retinal Drugs and Biologics Industry Drivers
  3. 2.3 Retinal Drugs and Biologics Industry Opportunities and Challenges
  4. 2.4 Retinal Drugs and Biologics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Retinal Drugs and Biologics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Retinal Drugs and Biologics Revenue by Region
  3. 3.2.1 Global Retinal Drugs and Biologics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Retinal Drugs and Biologics Revenue by Region (2021-2026)
  5. 3.2.3 Global Retinal Drugs and Biologics Revenue by Region (2027-2032)
  6. 3.2.4 Global Retinal Drugs and Biologics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Retinal Drugs and Biologics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Retinal Drugs and Biologics Sales by Region
  9. 3.4.1 Global Retinal Drugs and Biologics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Retinal Drugs and Biologics Sales by Region (2021-2026)
  11. 3.4.3 Global Retinal Drugs and Biologics Sales by Region (2027-2032)
  12. 3.4.4 Global Retinal Drugs and Biologics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Retinal Drugs and Biologics Revenue by Manufacturers
  2. 4.1.1 Global Retinal Drugs and Biologics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Retinal Drugs and Biologics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Retinal Drugs and Biologics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Retinal Drugs and Biologics Sales by Manufacturers
  6. 4.2.1 Global Retinal Drugs and Biologics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Retinal Drugs and Biologics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Retinal Drugs and Biologics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Retinal Drugs and Biologics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Retinal Drugs and Biologics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Retinal Drugs and Biologics Manufacturers, Product Type & Application
  13. 4.7 Global Retinal Drugs and Biologics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Retinal Drugs and Biologics Market CR5 and HHI
  16. 4.8.2 2025 Retinal Drugs and Biologics Tier 1, Tier 2, and Tier 3
5 Retinal Drugs and Biologics Market by Type
  1. 5.1 Global Retinal Drugs and Biologics Revenue by Type
  2. 5.1.1 Global Retinal Drugs and Biologics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Retinal Drugs and Biologics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Retinal Drugs and Biologics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Retinal Drugs and Biologics Sales by Type
  6. 5.2.1 Global Retinal Drugs and Biologics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Retinal Drugs and Biologics Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Retinal Drugs and Biologics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Retinal Drugs and Biologics Price by Type
6 Retinal Drugs and Biologics Market by Application
  1. 6.1 Global Retinal Drugs and Biologics Revenue by Application
  2. 6.1.1 Global Retinal Drugs and Biologics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Retinal Drugs and Biologics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Retinal Drugs and Biologics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Retinal Drugs and Biologics Sales by Application
  6. 6.2.1 Global Retinal Drugs and Biologics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Retinal Drugs and Biologics Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Retinal Drugs and Biologics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Retinal Drugs and Biologics Price by Application
7 Company Profiles
  1. 7.1 ALLERGAN
  2. 7.1.1 ALLERGAN Company Information
  3. 7.1.2 ALLERGAN Business Overview
  4. 7.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ALLERGAN Retinal Drugs and Biologics Product Portfolio
  6. 7.1.5 ALLERGAN Recent Developments
  7. 7.2 Alimera Sciences
  8. 7.2.1 Alimera Sciences Company Information
  9. 7.2.2 Alimera Sciences Business Overview
  10. 7.2.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Alimera Sciences Retinal Drugs and Biologics Product Portfolio
  12. 7.2.5 Alimera Sciences Recent Developments
  13. 7.3 Bausch & Lomb
  14. 7.3.1 Bausch & Lomb Company Information
  15. 7.3.2 Bausch & Lomb Business Overview
  16. 7.3.3 Bausch & Lomb Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bausch & Lomb Retinal Drugs and Biologics Product Portfolio
  18. 7.3.5 Bausch & Lomb Recent Developments
  19. 7.4 Bristol-Myers Squibb
  20. 7.4.1 Bristol-Myers Squibb Company Information
  21. 7.4.2 Bristol-Myers Squibb Business Overview
  22. 7.4.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bristol-Myers Squibb Retinal Drugs and Biologics Product Portfolio
  24. 7.4.5 Bristol-Myers Squibb Recent Developments
  25. 7.5 Genentech
  26. 7.5.1 Genentech Company Information
  27. 7.5.2 Genentech Business Overview
  28. 7.5.3 Genentech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Genentech Retinal Drugs and Biologics Product Portfolio
  30. 7.5.5 Genentech Recent Developments
  31. 7.6 Genzyme
  32. 7.6.1 Genzyme Company Information
  33. 7.6.2 Genzyme Business Overview
  34. 7.6.3 Genzyme Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Genzyme Retinal Drugs and Biologics Product Portfolio
  36. 7.6.5 Genzyme Recent Developments
  37. 7.7 Janssen Biotech
  38. 7.7.1 Janssen Biotech Company Information
  39. 7.7.2 Janssen Biotech Business Overview
  40. 7.7.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Janssen Biotech Retinal Drugs and Biologics Product Portfolio
  42. 7.7.5 Janssen Biotech Recent Developments
  43. 7.8 OCULAR THERAPEUTIX
  44. 7.8.1 OCULAR THERAPEUTIX Company Information
  45. 7.8.2 OCULAR THERAPEUTIX Business Overview
  46. 7.8.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Portfolio
  48. 7.8.5 OCULAR THERAPEUTIX Recent Developments
  49. 7.9 Swedish Orphan Biovitrum
  50. 7.9.1 Swedish Orphan Biovitrum Company Information
  51. 7.9.2 Swedish Orphan Biovitrum Business Overview
  52. 7.9.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Portfolio
  54. 7.9.5 Swedish Orphan Biovitrum Recent Developments
  55. 7.10 UCBCares
  56. 7.10.1 UCBCares Company Information
  57. 7.10.2 UCBCares Business Overview
  58. 7.10.3 UCBCares Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 UCBCares Retinal Drugs and Biologics Product Portfolio
  60. 7.10.5 UCBCares Recent Developments
  61. 7.11 AbbVie
  62. 7.11.1 AbbVie Company Information
  63. 7.11.2 AbbVie Business Overview
  64. 7.11.3 AbbVie Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 AbbVie Retinal Drugs and Biologics Product Portfolio
  66. 7.11.5 AbbVie Recent Developments
  67. 7.12 Roche
  68. 7.12.1 Roche Company Information
  69. 7.12.2 Roche Business Overview
  70. 7.12.3 Roche Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Roche Retinal Drugs and Biologics Product Portfolio
  72. 7.12.5 Roche Recent Developments
8 North America
  1. 8.1 North America Retinal Drugs and Biologics Market Size by Type
  2. 8.1.1 North America Retinal Drugs and Biologics Revenue by Type (2021-2032)
  3. 8.1.2 North America Retinal Drugs and Biologics Sales by Type (2021-2032)
  4. 8.1.3 North America Retinal Drugs and Biologics Price by Type (2021-2032)
  5. 8.2 North America Retinal Drugs and Biologics Market Size by Application
  6. 8.2.1 North America Retinal Drugs and Biologics Revenue by Application (2021-2032)
  7. 8.2.2 North America Retinal Drugs and Biologics Sales by Application (2021-2032)
  8. 8.2.3 North America Retinal Drugs and Biologics Price by Application (2021-2032)
  9. 8.3 North America Retinal Drugs and Biologics Market Size by Country
  10. 8.3.1 North America Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Retinal Drugs and Biologics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Retinal Drugs and Biologics Market Size by Type
  2. 9.1.1 Europe Retinal Drugs and Biologics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Retinal Drugs and Biologics Sales by Type (2021-2032)
  4. 9.1.3 Europe Retinal Drugs and Biologics Price by Type (2021-2032)
  5. 9.2 Europe Retinal Drugs and Biologics Market Size by Application
  6. 9.2.1 Europe Retinal Drugs and Biologics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Retinal Drugs and Biologics Sales by Application (2021-2032)
  8. 9.2.3 Europe Retinal Drugs and Biologics Price by Application (2021-2032)
  9. 9.3 Europe Retinal Drugs and Biologics Market Size by Country
  10. 9.3.1 Europe Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Retinal Drugs and Biologics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Retinal Drugs and Biologics Market Size by Type
  2. 10.1.1 China Retinal Drugs and Biologics Revenue by Type (2021-2032)
  3. 10.1.2 China Retinal Drugs and Biologics Sales by Type (2021-2032)
  4. 10.1.3 China Retinal Drugs and Biologics Price by Type (2021-2032)
  5. 10.2 China Retinal Drugs and Biologics Market Size by Application
  6. 10.2.1 China Retinal Drugs and Biologics Revenue by Application (2021-2032)
  7. 10.2.2 China Retinal Drugs and Biologics Sales by Application (2021-2032)
  8. 10.2.3 China Retinal Drugs and Biologics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Retinal Drugs and Biologics Market Size by Type
  2. 11.1.1 Asia Retinal Drugs and Biologics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Retinal Drugs and Biologics Sales by Type (2021-2032)
  4. 11.1.3 Asia Retinal Drugs and Biologics Price by Type (2021-2032)
  5. 11.2 Asia Retinal Drugs and Biologics Market Size by Application
  6. 11.2.1 Asia Retinal Drugs and Biologics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Retinal Drugs and Biologics Sales by Application (2021-2032)
  8. 11.2.3 Asia Retinal Drugs and Biologics Price by Application (2021-2032)
  9. 11.3 Asia Retinal Drugs and Biologics Market Size by Country
  10. 11.3.1 Asia Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Retinal Drugs and Biologics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Retinal Drugs and Biologics Market Size by Type
  2. 12.1.1 SAMEA Retinal Drugs and Biologics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Retinal Drugs and Biologics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Retinal Drugs and Biologics Price by Type (2021-2032)
  5. 12.2 SAMEA Retinal Drugs and Biologics Market Size by Application
  6. 12.2.1 SAMEA Retinal Drugs and Biologics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Retinal Drugs and Biologics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Retinal Drugs and Biologics Price by Application (2021-2032)
  9. 12.3 SAMEA Retinal Drugs and Biologics Market Size by Country
  10. 12.3.1 SAMEA Retinal Drugs and Biologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Retinal Drugs and Biologics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Retinal Drugs and Biologics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Retinal Drugs and Biologics Value Chain Analysis
  2. 13.1.1 Retinal Drugs and Biologics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Retinal Drugs and Biologics Production Mode & Process
  6. 13.2 Retinal Drugs and Biologics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Retinal Drugs and Biologics Distributors
  9. 13.2.3 Retinal Drugs and Biologics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst